08-05-2025 |
PM |
|
AUTL |
Autolus Therapeutics plc |
314.03 |
-0.26 |
-0.24 |
-0.24 |
Autolus Therapeutics GAAP EPS of -$0.26 misses by $0.01 [5/8/2025 7:15 AM] |
1.36 |
0.13 (10.16%) |
1.45 |
0.22 (17.89%) |
1.11 - 5.00 |
5,024,577 |
2,280,000 |
257,718 |
|
|
20-03-2025 |
PM |
|
AUTL |
Autolus Therapeutics plc |
484.34 |
-0.09 |
0.00 |
-0.44 |
Autolus Therapeutics GAAP EPS of -$0.86 beats by $0.03, revenue of $10.12M misses by $7.21M [3/20/2025 7:06 AM] |
1.69 |
-0.25 (-13.14%) |
2.07 |
0.13 (6.64%) |
1.66 - 6.63 |
4,240,664 |
890,000 |
18,242 |
|
|
12-11-2024 |
PM |
|
AUTL |
Autolus Therapeutics plc |
992.53 |
-0.31 |
-0.21 |
-0.26 |
Autolus Therapeutics GAAP EPS of -$0.31 misses by $0.09 [11/12/2024 7:03 AM] |
3.32 |
-0.19 (-5.41%) |
3.59 |
0.08 (2.28%) |
3.06 - 7.45 |
2,683,569 |
3,020,000 |
48,447 |
|
-
Autolus Therapeutics Q3 2024 Earnings Preview [11/11/2024 1:29 PM]
-
Autolus Therapeutics GAAP EPS of -$0.31 misses by $0.09 [11/12/2024 7:03 AM]
-
Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates [2024-11-12 07:00AM]
-
These Stocks Moved the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More [Nov-11-24 04:19PM]
-
These Stocks Are Moving the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More [Nov-11-24 02:23PM]
-
Autolus secures FDA approval for CAR-T cell therapy use in ALL [Nov-11-24 12:53PM]
-
What To Expect From Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings [Nov-11-24 07:12AM]
-
FDA approves new CAR-T competitor to Gileads Tecartus [Nov-11-24 07:04AM]
|
08-08-2024 |
PM |
|
AUTL |
Autolus Therapeutics plc |
1,040 |
-0.22 |
-0.19 |
-0.26 |
Autolus Therapeutics GAAP EPS of -$0.22 misses by $0.02 [8/8/2024 7:15 AM] |
3.63 |
-0.38 (-9.58%) |
0.0 |
0.0 (0.00%) |
2.01 - 7.45 |
1,125,778 |
1,030,000 |
0 |
|
|
17-05-2024 |
PM |
|
AUTL |
Autolus Therapeutics |
1,045 |
-0.24 |
-0.10 |
0.00 |
Autolus Therapeutics GAAP EPS of -$0.24 misses by $0.09, revenue of $10.09M misses by $14.96M [5/17/2024 7:07 AM] |
4.41 |
0.34 (8.35%) |
4.50 |
0.43 (10.57%) |
2.01 - 7.45 |
1,936,340 |
0 |
12,282 |
|
|
14-03-2024 |
PM |
|
AUTL |
Autolus Therapeutics plc |
937.80 |
-0.44 |
-0.26 |
-0.23 |
Autolus Therapeutics GAAP EPS of -$1.20 misses by $0.10, revenue of $1.69M misses by $0.01M [3/14/2024 7:02 AM] |
5.68 |
0.20 (3.65%) |
0.0 |
0.0 (0.00%) |
1.61 - 7.45 |
2,856,559 |
1,180,000 |
0 |
|
|
02-11-2023 |
PM |
|
AUTL |
Autolus Therapeutics plc |
488.07 |
-0.26 |
-0.24 |
-0.47 |
Autolus Therapeutics GAAP EPS of -$0.26 in-line [11/2/2023 7:22 AM] |
3.39 |
0.44 (14.92%) |
2.95 |
0.0 (0.00%) |
1.60 - 3.53 |
1,653,494 |
460,000 |
5,196 |
|
|
03-08-2023 |
PM |
|
AUTL |
Autolus Therapeutics plc |
545.18 |
-0.26 |
-0.22 |
-0.46 |
Autolus Therapeutics GAAP EPS of -$0.26 misses by $0.03 [8/3/2023 7:11 AM] |
3.00 |
-0.13 (-4.15%) |
0.0 |
0.0 (0.00%) |
1.60 - 3.79 |
338,897 |
530,000 |
0 |
|
|
07-03-2023 |
PM |
7:00 AM ET (Mar 7) |
AUTL |
Autolus Therapeutics plc |
334.00 |
-0.23 |
-0.37 |
-0.51 |
Autolus Therapeutics GAAP EPS of -$1.57 beats by $0.06, revenue of $6.36M misses by $4.47M [3/7/2023 7:06 AM] |
1.93 |
0.02 (1.05%) |
1.93 |
0.02 (1.05%) |
1.60 - 4.73 |
550,120 |
310,000 |
9,027 |
|
|
03-11-2022 |
PM |
7:00 AM ET (Nov 3) |
AUTL |
Autolus Therapeutics plc |
264.55 |
-0.47 |
-0.46 |
-0.47 |
Autolus Therapeutics GAAP EPS of -$0.47 in-line, revenue of $2.37M beats by $2.23M [11/3/2022 7:04 AM] |
2.63 |
-0.15 (-5.40%) |
0.0 |
0.0 (0.00%) |
1.96 - 7.90 |
335,518 |
90,000 |
0 |
|
|
04-08-2022 |
PM |
7:00 AM ET (Aug 4) |
AUTL |
Autolus Therapeutics plc |
260.03 |
-0.46 |
-0.42 |
-0.47 |
Autolus Therapeutics GAAP EPS of -$0.46 misses by $0.13 [8/4/2022 7:12 AM] |
3.27 |
0.48 (17.20%) |
3.92 |
-0.40 (-9.26%) |
1.96 - 7.90 |
224,367 |
100,000 |
51,552 |
|
|
05-05-2022 |
PM |
7:00 AM ET (May 5) |
AUTL |
Autolus Therapeutics plc |
294.54 |
-0.41 |
-0.51 |
-0.53 |
Autolus Therapeutics GAAP EPS of -$0.41 beats by $0.07, revenue of $0.17M in-line [5/5/2022 7:24 AM] |
3.26 |
0.05 (1.50%) |
3.20 |
-0.01 (-0.31%) |
3.00 - 8.23 |
171,532 |
220,000 |
10,234 |
|
|
10-03-2022 |
PM |
7:00 AM ET (Mar 10) |
AUTL |
Autolus Therapeutics plc |
271.99 |
-0.51 |
-0.50 |
-0.82 |
Autolus Therapeutics GAAP EPS of -$1.97 misses by $0.08, revenue of $2.33M misses by $4.87M [3/10/2022 7:05 AM] |
4.74 |
0.20 (4.41%) |
3.71 |
-0.13 (-3.39%) |
3.54 - 8.23 |
474,953 |
570,211 |
801 |
|
|
03-11-2021 |
PM |
7:00 AM ET (Nov 3) |
AUTL |
Autolus Therapeutics plc |
418.27 |
-0.47 |
-0.50 |
-0.72 |
Autolus Therapeutics EPS beats by $0.04, misses on revenue [11/3/2021 7:37 AM] |
5.95 |
0.41 (7.40%) |
5.62 |
0.08 (1.44%) |
4.60 - 12.29 |
720,906 |
200,000 |
3,553 |
|
|
05-08-2021 |
PM |
7:00 AM ET (Aug 5) |
AUTL |
Autolus Therapeutics plc |
391.04 |
-0.47 |
-0.50 |
-0.62 |
Autolus Therapeutics EPS beats by $0.04, beats on revenue [8/5/2021 7:15 AM] |
5.95 |
0.18 (3.03%) |
5.65 |
-0.12 (-2.08%) |
4.60 - 16.78 |
1,810,170 |
2,880,000 |
32,258 |
|
|
06-05-2021 |
PM |
7:00 AM ET (May 6) |
AUTL |
Autolus Therapeutics plc |
377.92 |
-0.53 |
-0.62 |
-0.60 |
Autolus Therapeutics EPS beats by $0.11, misses on revenue [5/6/2021 7:02 AM] |
5.10 |
-0.10 (-1.92%) |
5.10 |
0.0 (0.00%) |
4.94 - 17.19 |
825,759 |
700,000 |
4,655 |
|
|
04-03-2021 |
PM |
7:00 AM ET (Mar 4) |
AUTL |
Autolus Therapeutics plc |
479.03 |
-0.82 |
-0.75 |
-0.93 |
Autolus Therapeutics EPS misses by $0.10, beats on revenue [3/4/2021 7:09 AM] |
6.21 |
-0.20 (-3.12%) |
6.40 |
-0.01 (-0.16%) |
3.00 - 17.19 |
1,275,142 |
1,050,245 |
4,731 |
|
|
05-11-2020 |
PM |
7:00 AM ET (Nov 5) |
AUTL |
Autolus Therapeutics plc |
593.56 |
-0.72 |
-0.66 |
-0.61 |
Autolus Therapeutics EPS misses by $0.02 [11/5/2020 7:16 AM] |
12.01 |
0.07 (0.59%) |
11.94 |
0.0 (0.00%) |
3.00 - 17.19 |
57,812 |
98,044 |
376 |
|
|
06-08-2020 |
PM |
7:00 AM ET (Aug 6) |
AUTL |
Autolus Therapeutics plc |
729.88 |
-0.62 |
-0.70 |
-0.65 |
Autolus Therapeutics EPS beats by $0.10, misses on revenue [8/6/2020 7:12 AM] |
15.82 |
0.79 (5.26%) |
15.03 |
0.0 (0.00%) |
3.00 - 17.19 |
125,766 |
251,750 |
458 |
|
|